Asset Allocation
COVID-19 ‘Fault Lines’ Cause IMF to Downgrade Forecast
Supply chain disruptions and inflation pressures weigh down the World Economic Outlook.
Tag: vaccine
Asset Allocation
Get Ready for a Biotech M&A Comeback
RBC Capital, heartened by some billion-dollar-plus deals, sees a new buyout hunger in Big Pharma.
Coronavirus - COVID-19
Teamsters’ Pension Lawsuit Could Thwart Vaccine Mandates
The union says its pension fund’s mandatory vaccine policy violates collective bargaining agreements.
Market Moves
Welcome Big Tech Back to the Head of the Class
Amazon, Microsoft, and the gang are posting better returns and will keep on rising, says Barclays.
Corporate Moves
Mark Machin Joins the Board of Singapore VC Firm Serendipity Capital
The former head of CPPIB finished up his final day at the pension fund last week.
Market Moves
Endowment Index Rises 4.43% in First Quarter
Strong equity markets helped index outperform benchmark 60/40 index.
Research
OECD More Than Doubles US Economic Growth Forecast
Fiscal stimulus and a sustained vaccination pace are expected to spur the strongest GDP growth in 37 years.
Market Moves
Analysts’ Bullishness Means Stocks May Tank, BofA Warns
The bank’s contrarian indicator has been right before. Will it be now?
Asset Management Culture
CPPIB Chief Mark Machin Exits Amid Vaccine Uproar
The CEO of Canada’s largest pension fund traveled to the Middle East to get a shot. The plan’s credit head, John Graham, replaces him.
Coronavirus - COVID-19
IMF Upgrades Global Economic Forecast for 2021
Amid ‘exceptional uncertainty,’ World Economic Outlook projects 2021 growth of 5.5% after a 3.5% contraction in 2020.
Op-Ed: Which Injections Should Investors Watch in 2021?
Everyone is eager for vaccine news and numbers, but longtime investor Tony Waskiewicz argues the real portfolio boosters will be any actions from the Fed and Congress.
Market Moves
Will a Santa Claus Rally Grace This Yuletide?
Forget the 12 days of Christmas: Today marks the beginning of the traditional year-end market jump, LPL says, if it happens.
Market Moves
December Should Be OK, Just Not Its Usual Top-Tier Self
Muted market gains this month, strategists say, are overshadowed by blow-out earlier months.
Market Moves
The Market’s November Was Spectacular, So December Will Be … Down?
An LPL historical study shows the tricky dynamics for stocks in the year’s final two months.
Market Moves
3Q Corporate Earnings Look Better and Better, Yardeni Says
S&P 500 profits should be down just 7.1%, a big upgrade from more dire previous calls.